Brussels: Laboratory directors from Estonia’s growing science scene to the great research hubs of the west share a single worry this summer, and it concerns the research funding that will flow through Europe’s next framework programme. The numbers, once dazzling, have begun to slip.
When the Commission first sketched the tenth framework programme, still branded Horizon Europe, it proposed nearly doubling the budget to 175 billion euros for the 2028 to 2034 period. Coming from a current base of 88.5 billion euros, that figure electrified universities and startups that had spent years warning of underinvestment against better-funded rivals in the United States and Asia.
The euphoria has cooled. A preliminary proposal from the Cypriot presidency shaved the research envelope from 175 billion to 167.9 billion euros in current prices, a reminder that headline promises rarely survive the budget wars intact. Scientists read the cut as the opening move in a longer erosion, not the last word.
The programme keeps its familiar architecture. FP10 will run across four pillars, with the Commission promising bigger increases for excellent science and for the competitiveness-focused research that turns discoveries into products. Researchers welcome the structure, yet they insist that ambition without adequate money simply spreads the same grants more thinly across a hungrier field.
The stakes reach beyond the laboratory. Europe’s leaders have staked their competitiveness agenda on innovation, arguing that the continent must invent its way out of stagnation, and the framework programme is the single biggest lever they hold. A shrinking budget undercuts that story, and rivals abroad show no sign of easing their own spending.
The fight now folds into the wider battle over the long-term budget, where research competes with farming, defence and cohesion for a slice of a squeezed total. Negotiators do not expect a final figure until well into 2027, which leaves institutions planning under a cloud of uncertainty. Science|Business has tracked the shifting numbers in its budget analysis.
For now researchers can only lobby and wait as the figure drifts. Whether FP10 arrives as a transformation or a disappointment rests on choices ministers have yet to make. Until the ink dries, laboratories across the continent will keep drafting proposals against a target that could still move beneath their feet, and hope that Europe’s stated ambitions finally match its willingness to pay.
Universities are not waiting passively. Rectors’ groups and national academies have launched a coordinated lobbying push, arguing that every euro trimmed from research today compounds into lost competitiveness tomorrow. Their message to finance ministers is blunt: a framework programme is an investment, not an expense, and cutting it now would be a false economy.
